ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1595

Prevalence and Predictors of Depression in Patients with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry

Kyung-Eun Lee1, Ji-Hyoun Kang2, Dong-Jin Park2 and Shin-Seok Lee2, 1Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), 2Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Depression and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression is more common in patients with systemic lupus erythematosus (SLE) than in the general population. However, few studies have investigated predictors of depression in SLE patients and those studies have shown inconsistent results. This study evaluated the prevalence of, and risk factors for, depression in ethnically homogeneous Korean SLE patients.

Methods: In this study, 505 consecutive SLE patients were enrolled from KORNET registry. Demographic variables, SLE manifestations, laboratory findings, PGA, SLEDAI-2000, and SLICC damage index were recorded at enrollment. Based on the previous study, SLE Patients were identified as having depressive symptoms using the Beck Depression Inventory (BDI) ≥ 16, and we categorized the SLE patients, according to the BDI total score, into four groups: Group I (BDI 0–9), Group II (BDI 10–15), Group III (BDI 16–23) and Group IV (BDI 24–63). Multivariate logistic regression analyses were performed to identify independent risk factors for depression in SLE patients.

Results: Of the 505 patients, SLE patients were categorized as follows: Group I (n = 320), Group II (n = 88), Group III (n = 65), and Group IV (n = 32). In our cohort, total 97 (19.2%) patients were diagnosed as having depression (Group III and Group IV). The SLE patients with higher BDI score were older, and had higher proportions of current smokers and SLICC score >1, and on the other hands, lower levels of income and education. In the serologic findings, patients with higher BDI score had lower anti-dsDNA positivity and conversely higher aCL positivity. In the multivariate analysis, the following variables were remained as significant predictors of depression in SLE patients: current smokers, lower education and income levels, aCL positivity, and SLICC score >1.

Conclusion: Our results found that depression was prevalent in patients with SLE and multifactorial factors were associated with depression in SLE. Our study helps to guide target programs for those at high risk for depression in SLE.


Disclosure: K. E. Lee, None; J. H. Kang, None; D. J. Park, None; S. S. Lee, None.

To cite this abstract in AMA style:

Lee KE, Kang JH, Park DJ, Lee SS. Prevalence and Predictors of Depression in Patients with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/prevalence-and-predictors-of-depression-in-patients-with-systemic-lupus-erythematosus-results-from-the-korean-lupus-network-kornet-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-predictors-of-depression-in-patients-with-systemic-lupus-erythematosus-results-from-the-korean-lupus-network-kornet-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology